Abbott Wants New J&J Stent Patent Declared Invalid
A patent issued Tuesday and assigned to a Johnson & Johnson subsidiary has spawned two lawsuits over the lucrative and highly litigious market for drug-eluting stents....To view the full article, register now.
Already a subscriber? Click here to view full article